Cementos Bio Bio S.A. - Laporan Laba Rugi (TTM)

Cementos Bio Bio S.A.
CL ˙ SNSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Cementos Bio Bio S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 241,315 242,586 241,612 258,999 284,979 289,468 299,156 310,020 318,369 334,004 345,094 349,636 347,321 349,104 358,929 360,643 366,420 359,565 354,714 362,380
Change (%) 0.53 -0.40 7.20 10.03 1.58 3.35 3.63 2.69 4.91 3.32 1.32 -0.66 0.51 2.81 0.48 1.60 -1.87 -1.35 2.16
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 142,892 146,484 146,090 159,505 178,082 186,287 200,097 212,857 222,879 228,479 228,187 227,060 221,028 219,413 222,852 220,941 223,833 222,102 221,258 226,782
Change (%) 2.51 -0.27 9.18 11.65 4.61 7.41 6.38 4.71 2.51 -0.13 -0.49 -2.66 -0.73 1.57 -0.86 1.31 -0.77 -0.38 2.50
% of Revenue 59.21 60.38 60.46 61.59 62.49 64.36 66.89 68.66 70.01 68.41 66.12 64.94 63.64 62.85 62.09 61.26 61.09 61.77 62.38 62.58
Gross Operating Profit 98,422 96,102 95,522 99,494 106,897 103,181 99,059 97,163 95,489 105,525 116,907 122,576 126,293 129,692 136,078 139,702 142,587 137,462 133,456 135,598
Change (%) -2.36 -0.60 4.16 7.44 -3.48 -3.99 -1.91 -1.72 10.51 10.79 4.85 3.03 2.69 4.92 2.66 2.06 -3.59 -2.91 1.60
% of Revenue 40.79 39.62 39.54 38.41 37.51 35.64 33.11 31.34 29.99 31.59 33.88 35.06 36.36 37.15 37.91 38.74 38.91 38.23 37.62 37.42
SG&A 76,583 73,039 71,373 75,091 80,764 86,095 89,625 92,285 93,624 94,110 94,845 94,199 93,913 94,685 96,004 97,047 98,650 97,800 98,128 98,968
Change (%) -4.63 -2.28 5.21 7.55 6.60 4.10 2.97 1.45 0.52 0.78 -0.68 -0.30 0.82 1.39 1.09 1.65 -0.86 0.34 0.86
% of Revenue 31.74 30.11 29.54 28.99 28.34 29.74 29.96 29.77 29.41 28.18 27.48 26.94 27.04 27.12 26.75 26.91 26.92 27.20 27.66 27.31
R&D
Change (%)
% of Revenue
OpEx 219,476 219,523 217,463 234,596 258,845 272,382 289,722 305,142 316,503 322,589 323,194 321,388 315,070 314,218 319,008 318,380 322,897 320,348 319,781 325,795
Change (%) 0.02 -0.94 7.88 10.34 5.23 6.37 5.32 3.72 1.92 0.19 -0.56 -1.97 -0.27 1.52 -0.20 1.42 -0.79 -0.18 1.88
% of Revenue 90.95 90.49 90.01 90.58 90.83 94.10 96.85 98.43 99.41 96.58 93.65 91.92 90.71 90.01 88.88 88.28 88.12 89.09 90.15 89.90
Operating Income 21,839 23,062 24,149 24,404 26,133 17,086 9,435 4,878 1,866 11,415 21,900 28,247 32,250 34,887 39,921 42,263 43,523 39,217 34,934 36,585
Change (%) 5.60 4.71 1.05 7.09 -34.62 -44.78 -48.30 -61.75 511.80 91.85 28.99 14.17 8.18 14.43 5.87 2.98 -9.89 -10.92 4.73
% of Revenue 9.05 9.51 9.99 9.42 9.17 5.90 3.15 1.57 0.59 3.42 6.35 8.08 9.29 9.99 11.12 11.72 11.88 10.91 9.85 10.10
Interest Expense -4,683 -4,038 -3,426 -2,865 -2,715 -3,561 -4,715 -6,675 -8,900 -11,141 -13,070 -14,116 -14,640 -14,353 -13,555 -12,453 -11,518 -10,708 -10,296 -10,200
Change (%) -13.77 -15.15 -16.40 -5.22 31.17 32.39 41.57 33.34 25.18 17.31 8.01 3.71 -1.96 -5.56 -8.13 -7.51 -7.03 -3.85 -0.93
% of Revenue -1.94 -1.66 -1.42 -1.11 -0.95 -1.23 -1.58 -2.15 -2.80 -3.34 -3.79 -4.04 -4.22 -4.11 -3.78 -3.45 -3.14 -2.98 -2.90 -2.81
Net Income 12,829 13,763 15,123 16,645 20,671 26,879 23,189 21,545 17,289 10,560 14,820 16,084 17,235 22,797 29,038 32,901 36,837 32,427 27,359 27,108
Change (%) 7.28 9.89 10.06 24.19 30.03 -13.73 -7.09 -19.75 -38.92 40.34 8.53 7.16 32.27 27.38 13.30 11.96 -11.97 -15.63 -0.92
% of Revenue 5.32 5.67 6.26 6.43 7.25 9.29 7.75 6.95 5.43 3.16 4.29 4.60 4.96 6.53 8.09 9.12 10.05 9.02 7.71 7.48

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista